Ayuk J, Sheppard M. Growth hormone and its disorders. Postgrad Med J. 2006;24–30.
4.
Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis and management. Endocrine Reviews. 2004;102–52.
5.
Holdaway I, Rajasoorya C. Epidemiology of acromegaly. Pituitary. 1999;29–41.
6.
Melmed S. Clinical perspective: Acromegaly and cancer: not a problem? JCEM. 2001;(7):2929–34.
7.
Bates A, Van’t Hoff W, Jones J, Clayton R. An audit of outcome of treatment in acromegaly. QJMed. 1993;293–9.
8.
Ezzat S, Melmed S. Are patients with acromegaly at increased risk for neoplasia? Clinical review. 1991;245–9.
9.
Barzilay J, Heatley G, Cushing G. Benign and malignant tumors in patients with acromegaly. Arch Intern Med. 1991;1629–32.
10.
Smith M. Colonic polyps in acromegaly. Ann Intern Med. 1991;232–3.
11.
Ezzat S, Strom C, Melmed S. Colon polyps in acromegaly. Ann Intern Med. 1991;754–5.
12.
Orme S, Mcnally R, Cartwright R, Belchetz P. Mortality and cancer incidence in acromegaly: a retrospective cohort study. JCEM. 1998;2730–4.
13.
Jenkins P, Fairclough P. Colorectal neoplasia in acromegaly. Clin Endocrinol (Oxf). 2001;2929–34.
Ladas S, Thalassinos N, Ioannides G, Raptis S. Does acromegaly really predispose to an increased prevalence of gastrointestinal tumours? Clin Endocrinol (Oxf). 1994;597–601.
16.
Terzolo M, Reimondo G, Gasperi M, Cozzi R, Pivonello R, Vitale G. Colonoscopic screening and follow-up in patients with acromegaly: a multicentre study in Italy. JCEM. 2005;84–90.
17.
Beentjes J, Van Gorkom B, Sluiter B, De Vries E, Kleibeuker J, Dullaart R. One year growth hormone replacement therapy does not alter colonic epithelial cell proliferation in growth hormone deficient adults. Clin Endocrinol (Oxf). 2000;457–62.
18.
Popovic V, Damjanovic S, Micic D, Nesovic M, Djurovic M, Petakov M. Increased incidence of neoplasia in patients with pituitary adenomas. Clin Endocrinol. 1998;441–5.
19.
Colao A, Balzano A, Ferone D, Panza N, Grande G, Marzullo P. Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly. Clin Endocrinol (Oxf). 1997;23–8.
20.
Renehan A, Bhaskar P, Painter J, Dwyer O, Haboubi S, Varma N, et al. The prevalence and characteristics of colorectal neoplasia in acromegaly. JCEM. 2000;3417–24.
21.
Bogazzi F, Cosci C, Sardella C, Costa A, Manetti L, Gasperi M. Identification of acromegalic patients at risk of developing colonic adenomas. JCEM. 2006;1351–6.
22.
Wynter C, Walsh M, Higuchi T, Leggett B, Young J, Jass J. Methylation patterns define two types of hyperplastic polyps associated with colorectal cancer. Gut. 2004;573–80.
23.
Jass J. Hyperplastic polyps and colorectal cancer: is there a link? Clinical Gastroenterology and Hepatology. 2004;1–8.
24.
Edmondson S, Thumiger S, Werther G, Wraight C. Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems. Endocrine Reviews. 2003;737–64.
25.
Rokkas T, Pistiolas D, Sechopoulos P, Margantinis G, Koukoulis G. Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis. World Journal of Gastroenterology. 2008;3484–9.
26.
Renehan A, Dwyer O, Shalet S, S. Guidelines for colonoscopic screening in acromegaly are inconsistent with those for other risk groups. Gut. 2003;1071–2.
27.
Turner H, Wass J. Modern approach to treating acromegaly. Quarterly Journal of Medicine. 2000;1–6.
28.
Melmed S, Colao A, Barkan A, Molitch M, Grossman A, Kleinberg D. Guidelines for acromegaly management: an update. JCEM. 2009;1509–17.
29.
Jenkins P, Fairclough P. Screening guidelines for colorectal cancer and polyps in patients with acromegaly. Gut. 2002;13–4.
30.
Chobanian S, Ness V, Winters M, Cattau C, E. Skin tags as a marker for adenomatous polyps of the colon. KBC Zemun, Služba endokrinologije. 1985;(6):892–3.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
